| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Triamcinolone acetate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Mometasone furoate monohydrate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Corticosteroids for oropharynx |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Topical form corticosteroids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Hydrocortisone lotions/dressng |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Hydrocortisone compound preprations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Hydrocortisone+antimicrobials |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Hydrocortisone/neomycin cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Beclomethasone diprop [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Betamethasone + antimicrobials |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Clobetasone butyrate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Stiedex LPN oily cream 15g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Triamcinolone acetonide [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Budesonide Topical |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Hydrocortisone acetate [topical] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fluticasone propionate[skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Corticosteroids [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Corticosteroids cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Stiedex LPN oily cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Budesonide refill |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Respiratory mometasone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Mometasone-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Product containing mometasone in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Beclomethasone dipropionate 400micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Beclomethasone dipropionate 200micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fluocinolone acetonide+clioquinol 0.025%/3% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fluocinolone acetonide+clioquinol 0.025%/3% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Product containing dexamethasone and tobramycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Mometasone furoate 400micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Mometasone furoate 200micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Beclometasone dipropionate 50micrograms CFC-free inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Beclometasone dipropionate 50micrograms CFC-free breath-actuated aerosol inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Beclometasone dipropionate 100micrograms CFC-free inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Beclometasone dipropionate 100micrograms CFC-free breath-actuated aerosol inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Hydrocortisone 1% aqueous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Clioquinol+hydrocortisone 3%/0.5% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Flunisolide 250mcg/inh inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Iodoquinol+hydrocortisone 1%/1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Halobetasol propionate 0.05% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Halobetasol propionate 0.05% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Hydrocortisone cypionate 10mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fluorometholone acetate 0.1% suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Rimexolone 1% suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Prednisolone acetate 1% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Dexamethasone acetate 8 mg/mL suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Prednisolone acetate 10 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Product containing precisely triamcinolone diacetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Methylprednisolone sodium su 125mg/2mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Methylprednisolone sodium su 40mg/mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Betamethasone valerate 0.12% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Betamethasone valerate 0.12% aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Loteprednol etabonate 5 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Amcinonide 1 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Diflorasone diacetate 0.05% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Diflorasone diacetate 0.05% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Beclomethasone dipropionate 42mcg inhalation aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Flunisolide 250mcg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Flunisolide 0.025% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Flurandrenolide 4mcg/sq/cm tape |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Flurandrenolide 4mcg tape |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fludroxycortide 500 microgram/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Dexamethasone acetate 8mg/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Methylprednisolone sodium succinate 40mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Methylprednisolone sodium succinate 125mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Methylprednisolone sodium succinate 1g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Methylprednisolone sodium succinate 500mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Methylprednisolone sodium succinate 2g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Hydrocortisone valerate 2 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone valerate 2 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Betamethasone dipropionate 0.05% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Betamethasone dipropionate 0.05% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Triamcinolone diacetate 25mg/mL injection suspension ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Triamcinolone diacetate 40mg/mL injection suspension ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Betamethasone dipropionate 0.5mg/g cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Betamethasone dipropionate 0.5mg/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Dexamethasone acetate 16mg/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Betamethasone dipropionate 0.5mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Methylprednisolone sodium succinate 500g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Betamethasone dipropionate 0.5% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Methylprednisolone sodium su 40mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fluticasone propionate 220mcg/actn aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fluticasone propionate 110mcg powder for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fluticasone propionate 250mcg/spr inhalant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fluticasone propionate 110mcg/actn aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fluticasone propionate 44mcg/actn aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fluticasone propionate 50mcg/spr inhalant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Fluticasone propionate 125mcg/spr inhalant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Beclomethasone dipropionate 42mcg inhaler (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Triamcinolone acetonide 1 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Triamcinolone acetonide 55mcg/spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Triamcinolone acetonide 0.05% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Triamcinolone acetonide 200mcg/spr |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
| Triamcinolone acetonide 40mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adrenal hormone agent |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]